EnGen Bio Passes 3rd Pilot Project for DTC Genetic Testing Service

[Asia Economy Reporter Ji-hwan Park] Precision diagnostic platform specialist NGENBIO announced on the 25th that it has passed the third pilot project for the DTC (Direct-to-Consumer) genetic testing service certification, led by the Ministry of Health and Welfare.

NGENBIO passed certification for an additional 25 types in this third pilot project, following the second pilot project (45 types) in March last year. Among the 70 types that passed, some items will be classified into detailed subcategories to provide consumers with more diverse and accurate testing services.

The items added in this third pilot project include nine nutrients such as lutein and zeaxanthin, vitamin A, and vitamin E, as well as health management-related items with high consumer interest such as post-exercise recovery ability, alcohol dependence, nicotine dependence, and insomnia. Beauty-related items such as gray hair, acne occurrence, and male pattern baldness were also included.

NGENBIO’s DTC genetic testing service, Ginorhythm, has been continuously growing since its launch last year, with over 100,000 tests already conducted. In particular, the company plans to upgrade differentiated content based on individual customers’ genetic test results and develop mobile services for consumer convenience to present optimal personalized health management solutions.

Choi Dae-chul, CEO of NGENBIO, stated, "With the passage of this third pilot project, we can provide consumers with more sophisticated genetic testing services." He added, "Based on this, we will continuously accumulate detailed genetic testing data and build a platform integrating disease genetic data and microbiome data."

This content was produced with the assistance of AI translation services.